ArticleFrontiers in neurology2022

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis.

Jung-Min Pyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.